Últimas noticias sobre CRISPR Therapeutics (NASDAQ:CRSP) Bolsa

CRISPR Therapeutics

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

CRISPR Therapeutics AG

Vision Marine Technologies Inc. ("Vision Marine") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>), a leader in electric marine propulsion systems, is pleased to announce the successful completion of an at-the-market ("ATM") offering, raising gross proceeds of approximately US$11.75 million and net proceeds of approximately US$11.2 million. We intend to use the net proceeds from the offering for general corporate purposes, including strategic acquisitions aimed at expanding our market presence and enhancing our technological capabilities.
Following the completion of today's ATM executions, the total number of common shares issued and outstanding will be 5,522,029, and Vision Marine will have approximately US$7.1 million of cash available.
This capital infusion positions Vision Marine to capitalize on the growing demand for sustainable boating solutions. By leveraging these funds, we aim to accelerate our growth trajectory and solidify our leadership in the electric marine propulsion sector.

News

Offerings

VMAR

Vision Marine Technologies Secures Over $11.7M Through At-the-Market Offering, Aiming To Accelerate Growth Trajectory And Solidify Leadership In The Electric Marine Propulsion Sector.

Intellia Therapeutics's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NYSE">NTLA</a>) short percent of float has risen 4.73% since its last report. The company recently reported that it has 19.81 million shares sold short, which is 22.15% of all regular shares that are available for trading. Based on its trading volume, it would take traders 9.36 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Intellia Therapeutics Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736541923_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Intellia Therapeutics has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Intellia Therapeutics's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Intellia Therapeutics's peer group average for short interest as a percentage of float is 14.00%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

NTLA

Peering Into Intellia Therapeutics's Recent Short Interest

Howard Hughes Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HHH#NYSE">HHH</a>) short percent of float has risen 12.42% since its last report. The company recently reported that it has 1.73 million shares sold short, which is 5.61% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.73 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Howard Hughes Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736541917_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Howard Hughes Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Howard Hughes Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Howard Hughes Holdings's peer group average for short interest as a percentage of float is 0.96%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Howard Hughes Holdings's Recent Short Interest

Opendoor Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NYSE">OPEN</a>) short percent of float has risen 4.46% since its last report. The company recently reported that it has 73.67 million shares sold short, which is 12.19% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.79 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Opendoor Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736541912_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Opendoor Technologies has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Opendoor Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Opendoor Technologies's peer group average for short interest as a percentage of float is 5.66%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

OPEN

(OPEN) - Analyzing Opendoor Technologies's Short Interest

Each week,&nbsp;Benzinga's Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Read Also:&nbsp;<a href="https://www.benzinga.com/trading-ideas/25/01/42802731/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-2024-where-do-tesla-nvidia-gamestop-trump-media-stocks-rank" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In 2024 — Where Do Tesla, Nvidia, GameStop, Trump Media Stocks Rank?</a>
Here&#8217;s a look at the Benzinga Stock Whisper Index for the week ending Jan. 10:
M&amp;T Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>): The regional bank saw strong interest from Benzinga readers during the week, which comes ahead of the company's fourth-quarter financial results. Analysts expect the company to report earnings per share of $3.73, up from $2.81 in last year's fourth quarter and to report revenue of $2.34 billion, up from $2.30 billion in last year's fourth quarter. The company has beaten analyst estimates for revenue and earnings per share in seven of the last 10 quarters for each. Analysts <a href="https://www.benzinga.com/quote/MTB/analyst-ratings">have spoken positively </a>of regional banks recently with Truist <a href="https://www.benzinga.com/general/market-summary/25/01/42871340/regional-banks-can-thrive-despite-big-bank-dominance-truist-securities-highlights-three-key-paths-for-thriving-regional-banks">initiating the stock</a> with a Buy rating and $233 price target. Barclays maintained an Equal-weight rating and raised the price target from $228 to $235. Truist said regional banks have differentiated growth, disciplined capital allocation and can navigate to the evolving landscape.
The<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"> Benzinga Pro chart</a> below shows the five-day trading range of MTB with shares down on the week. The stock remains up over 35% over the last year.
<figure class="wp-block-image size-full"><a href=" https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="993" height="496" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145206/Screenshot-290.png" alt="" class="wp-image-728860" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145206/Screenshot-290.png 993w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145206/Screenshot-290-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145206/Screenshot-290-768x384.png 768w" sizes="(max-width: 993px) 100vw, 993px" /></a></figure>
DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>): The sports betting and online gaming company saw increased interest from readers during the week, which comes as<a href="https://www.benzinga.com/general/sports/25/01/42829221/how-to-watch-nfl-playoffs-super-bowl-lix-betting-odds-will-history-be-made-by-chiefs-or-lions"> the NFL Playoffs </a>are set to kick off on Jan. 11. The NFL remains one of the most bet on sports worldwide and a major source of revenue for DraftKings. Peer company Flutter recently lowered guidance for the full fiscal year due to <a href="https://www.benzinga.com/general/sports/25/01/42884959/detroit-lions-take-a-bite-out-of-sportsbooks-analyst-advises-patience-after-flutter-cuts-guidance">unfavorable NFL outcomes</a>, something DraftKings had already done and commented on. DraftKings could be getting more attention as the company got ahead of the guidance and NFL warnings earlier than peers and shares could now look attractive. DraftKings shares were up around 10% over the last five days and the stock is up around 18% over the last year.
<figure class="wp-block-image size-full"><a href=" https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="499" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145223/Screenshot-291.png" alt="" class="wp-image-728861" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145223/Screenshot-291.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145223/Screenshot-291-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145223/Screenshot-291-768x384.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
TJX Companies (NYE:TJX): The discount retailer, which owns the T.J. Maxx, Marshalls and Home Goods brands, saw increased interest during the week. The retailer was recently <a href="https://www.benzinga.com/trading-ideas/24/12/42694713/super-saturday-foot-traffic-surges-sales-hit-157-million-potential-winners-emerge">highlighted by Benzinga</a> as a potential winner from Super Saturday, the shopping holiday that is the last Saturday before Christmas. A Placer.ai report said foot traffic at retailers on Super Saturday was up an average of 58% compared to daily averages in 2024. T.J. Maxx foot traffic was up 4.6% on a year-over-year basis for Super Saturday according to the report. In recent weeks, the retailer has received several <a href="https://www.benzinga.com/quote/TJX/analyst-ratings">price target increases</a> from analysts, including Wells Fargo, UBS and Bernstein at $120, $151 and $145 respectively. The stock is up around 28% over the last year.
<figure class="wp-block-image size-full"><a href=" https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145239/Screenshot-292.png" alt="" class="wp-image-728862" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145239/Screenshot-292.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145239/Screenshot-292-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145239/Screenshot-292-768x386.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Insmed Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>): The biopharmaceutical company saw increased interest after <a href="https://investor.insmed.com/2025-01-10-Insmed-Provides-Business-Update-at-43rd-Annual-J-P-Morgan-Healthcare-Conference">sharing </a>a business update at the JPMorgan Healthcare Conference, including 2025 guidance. The company said ARIKAYCE, its first commercial product, is expected to have full year revenue of $363.7 million globally, including $254.8 million in the United States. Guidance for ARIKAYCE for 2025 was set at a range of $405 million to $425 million. Insmed also shared an update on its other pipeline drugs with an NDA submitted in December 2024 for Brensocatib, expected to launch in the third quarter of 2025. The company also announced several other pipeline updates, which may have investors taking a new look at the stock. Insmed previously appeared on the Stock Whisper Index<a href="https://www.benzinga.com/trading-ideas/24/11/41856335/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-42"> back in November</a> after reporting third-quarter financial results and receiving several analyst updates. Shares fell during the week, but are up over 130% over the last year.
<figure class="wp-block-image size-full"><a href=" https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="504" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145253/Screenshot-294.png" alt="" class="wp-image-728864" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145253/Screenshot-294.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145253/Screenshot-294-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145253/Screenshot-294-768x388.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Trane Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TT#NYSE">TT</a>): The commercial and residential HVAC company appears on the list after seeing a boost in interest from readers. The company announced it will report fourth-quarter financial results on Jan. 30. Analysts expect the company to report earnings per share of $2.52, up from $2.17 in last year's fourth quarter and to report revenue of $4.77 billion, up from $4.43 billion in last year's fourth quarter. The company has beaten earnings estimates in more than 10 straight quarters and beaten revenue estimates in nine of the last 10 quarters, including three straight quarters. Trane Technologies recently <a href="https://investors.tranetechnologies.com/news-and-events/news-releases/news-release-details/2025/Trane-Technologies-Completes-Acquisition-of-BrainBox-AI/default.aspx">announced </a>the closing of its acquisition of BrainBox AI, which it announced in December 2024. Brain Box AI is a pioneer in autonomous HVAC controls and generative AI building technology, according to the announcement. While HVAC might not be a sector that jumps out as an AI use case, the company's acquisition could be the reason why readers are paying more attention to Trane Technologies. Analysts were mixed <a href="https://www.benzinga.com/quote/TT/analyst-ratings">in recent weeks </a>with Wells Fargo lowering the price target, RBC raising the price target and Barclays maintaining a Buy rating and $500 price target.
<figure class="wp-block-image size-full"><a href=" https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="505" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145308/Screenshot-295.png" alt="" class="wp-image-728865" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145308/Screenshot-295.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145308/Screenshot-295-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10145308/Screenshot-295-768x388.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Stay tuned for next week's report, and follow Benzinga Pro for all the latest headlines and&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/24/12/42490690/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">December 13</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/24/12/42628286/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-including-qubt-qbts" target="_blank" rel="noreferrer noopener">December 20</a></li>
<li><a href="https://www.benzinga.com/media/24/12/42709387/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">December 27</a></li>
<li><a href="https://www.benzinga.com/25/01/42798998/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">January 3 </a></li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42638753/quantum-computing-the-new-ai-a-look-at-the-rapidly-expanding-market-and-top-stocks-for-2025" target="_blank" rel="noreferrer noopener">Quantum Computing: The New AI? A Look at the Rapidly Expanding Market and Top Stocks For 2025</a></li>
</ul>

Exclusives

DKNG

INSM

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Rumors

SWTX

Watching SpringWorks Therapeutics; Shares Trading Higher, Traders Circulate M&A Blog Comments Suggesting The Co Has Received Takeover Interest

WIIM

PPIH

Perma-Pipe International shares are trading higher after the company announced it received a $43 million contract award from the Middle East region.

<a href="https://www.macrumors.com/2025/01/10/apple-pay-synchrony/" title="https://www.macrumors.com/2025/01/10/apple-pay-synchrony/">https://www.macrumors.com/2025/01/10/apple-pay-synchrony/</a>

'Apple Pay Now Lets You Pay Later With Synchrony; Synchrony Was Added To A List Of Apple Pay Installment Providers In The U.S. In An Apple Support Document That Was Updated Today, Joining Affirm And Klarna' - MacRumors

The December jobs report upended market expectations, forcing top Wall Street investment banks to abandon their forecast for further interest rate cuts in 2025. A labor market exceeding even the most optimistic estimates has traders now bracing for the unthinkable: the return <a href="https://www.benzinga.com/topic/interest-rates">of interest rate hikes.</a>
In a note released Friday, Bank of America economist Aditya Bhave said the bank no longer expects any additional rate cuts this year, a sharp U-turn from its prior prediction of two reductions. 
"The December jobs report was extremely solid across the board," Bhave said, adding, "We think this A+ jobs report closes the door for additional rate cuts."
<h1 class="wp-block-heading">December&#8217;s A+ Jobs Report</h1>
The December nonfarm payrolls figure came in at 256,000, far exceeding the bank's own expectations of 175,000 and crushing the consensus estimate of 160,000. The robust labor market data signals continued resilience in the U.S. economy, with wage growth outpacing inflation and supporting purchasing power.
Bank of America also highlighted the strength of income growth, with the aggregate payrolls index — a proxy for total wage income — rising 0.4% month-over-month and 5.4% on a three-month annualized basis.
With wages growing faster than prices, consumers retain significant spending power, offsetting fears of an economic slowdown, according to the investment bank. 
Yet, while this is good news for the U.S. consumer, it is less so the Federal Reserve grappling with a resurgence in price pressures. 
<h1 class="wp-block-heading">&#8216;The Conversation Should Move To Hikes&#8217;</h1>
Bhave said inflation remains "above target" and warned that risks are skewed to the upside, noting robust economic activity as a key factor. 
"The conversation should move to hikes," he said, indicating that the Federal Reserve could raise rates if core inflation exceeds 3% or long-term inflation expectations lose its anchor.
This marks a dramatic shift in tone, with Bank of America not only ruling out further easing despite earlier predictions but also flagging the potential risk of a new hiking period. 
In November 2024, the core Personal Consumption Expenditure price index — Fed&#8217;s favorite inflation gauge — was up 2.8% annually.
<h1 class="wp-block-heading">Market Reaction: Betting On A Long Wait</h1>
Traders in the fed funds futures market have drastically recalibrated their expectations. Prior to the jobs report, a rate cut in the first quarter of 2025 was seen as a distinct possibility.
Now, the odds of a cut by the Fed's March meeting have dwindled to just 23%, according to CME's FedWatch tool.
The first meeting with significant probabilities of a cut now appears to be in July, with a 70% chance of a 25-basis-point reduction. Even then, a fully priced-in rate cut is unlikely until October 2025, fed futures indicate.
The recalibration of interest rate cuts is producing shockwaves across markets. On Friday, indices witnessed notable declines, with the S&amp;P 500 — tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) — down by 1.4% during afternoon trading in New York.
Meanwhile, speculation over a potential rate hike is gaining momentum.
On Kalshi, a CFTC-regulated prediction platform, the market for "Next Fed rate hike?" has surged to a 33% probability of an increase in the fed funds rate by Dec. 31, 2025, up sharply from 20% before the jobs report. For every dollar wagered on "Yes," the payout now stands at $3.
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42922299/wall-street-tumbles-on-blowout-payrolls-oil-rallies-to-76-us-dollar-hits-26-month-highs-whats-driving-markets-friday">Wall Street Tumbles On Blowout Payrolls, Oil Rallies To $76, US Dollar Hits 26-Month Highs: What&#8217;s Driving Markets Friday?</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Broad U.S. Equity ETFs

Federal Reserve

Markets

ETFs

Bank Of America Scraps Interest Rate Cut Calls, Betting Markets Go Haywire As Hiking Panic Mounts

Cryptocurrency markets are trading higher on Friday after experiencing significant volatility throughout the day.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$94,777</td>
<td>+3.3%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$3,266</td>
<td>+2.5%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$188.06</td>
<td>+2.3%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.36</td>
<td>+3.4%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.3323</td>
<td>+4.7%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00002151</td>
<td>+2.8%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume decreasing by 6.2% and daily active addresses falling by 0.02%. Transactions greater than $100,000 are down from 11,991 to 11,484 in a single day. Exchanges netflows are down by 335%.</li>
<li>Coinglass data reports 111,905 traders were liquidated in the past 24 hours for $381.10 million.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42908193/exclusive-answering-key-questions-about-bitcoins-future-before-inauguration">EXCLUSIVE: Answering Key Questions About Bitcoin&#8217;s Future 10 Days Before The Inauguration</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42906328/crypto-fear-and-greed-index-hits-lowest-level-since-october-as-bitcoin-falls-under-92k-dogecoin-and-shiba-inu-trade-in-red">Crypto Fear And Greed Index Hits Lowest Level Since October As Bitcoin Falls Under $92K, Dogecoin And Shiba Inu Trade In Red</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42921919/bitcoin-takes-stairs-up-and-elevator-down-on-labor-market-data-whats-next">Bitcoin Takes &#8216;Stairs Up&#8217; And &#8216;Elevator Down&#8217; On Labor Market Data: What&#8217;s Next?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42904654/coinbase-subpoenaed-over-polymarket-involvement-federal-agency-seeks-customer-information">Coinbase Subpoenaed Over Polymarket Involvement, Federal Agency Seeks Customer Information</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin SV (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BSV</a>)</td>
<td> $61.95</td>
<td>+21.3%</td>
</tr>
<tr>
<td>Algorand (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/algo/usd">ALGO</a>)</td>
<td> $0.3814</td>
<td>+!2.6%</td>
</tr>
<tr>
<td>Sui (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">SUI</a>)</td>
<td> $5.20</td>
<td>+11.4%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices changing course to green after a highly volatile day, crypto trader Altcoin Sherpa <a href="https://x.com/ColdBloodShill/status/1877766962488496426">acknowledged</a> the tough market conditions but expressing relief it&#8217;s Friday. 
He predicts a "weekend altcoin season" to begin tomorrow.
Altcoin Sherpa believes Bitcoin is in a bounce zone, with high volatility suggesting potential for modest short-term gains. He advises scalping for most trades.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> still a bounce region imo. volatility is high but guessing we go up a little bit in the short term. Still think all trades should be scalps for the most part, though <a href="https://t.co/n0Wnlo30rK">https://t.co/n0Wnlo30rK</a> <a href="https://t.co/Jov4F6vm7F">pic.twitter.com/Jov4F6vm7F</a>
&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1877773333069967764?ref_src=twsrc%5Etfw">January 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Additionally, he <a href="https://x.com/AltcoinSherpa/status/1877777158711435423">sees</a> Bitcoin as having momentarily bottomed, while altcoins are expected to continue their slight rebounds.
According to Glassnode data, new investors now hold 49.6% of Bitcoin&#8217;s liquidity, indicating that seasoned investors have sold during the uptrend, with strong demand from new buyers absorbing the sell pressure.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The percentage of <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> wealth held by new investors (coins aged &lt; 3m) has surged, now representing 49.6% of the network liquidity. This infers that mature investors have meaningfully distributed coins across the uptrend, with new demand absorbing the sell-side pressure. <a href="https://t.co/1qX9EuVgGA">pic.twitter.com/1qX9EuVgGA</a>
&mdash; glassnode (@glassnode) <a href="https://twitter.com/glassnode/status/1877763363796562264?ref_src=twsrc%5Etfw">January 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42919731/bitcoin-to-bounce-back-in-q1-but-beware-20-corrections-analysts-warn">Bitcoin To Bounce Back In Q1 But Beware 20% Corrections, Analysts Warn</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ALGO

$BSV

$BTC

$DOGE

$ETH

$SHIB

$SOL

$SUI

$XRP

Bitcoin, Ethereum, XRP, Dogecoin In The Green On Friday: 'Weekend Altcoin Season' Coming?

President Joe Biden's administration on Friday renewed deportation relief that currently covers 900,000 immigrants from Venezuela, El Salvador, Ukraine and Sudan, a move that would delay any attempts by President-elect Donald Trump to sunset those protections.
The U.S. Department of Homeland Security (DHS) extended enrollment in the Temporary Protected Status (TPS) program for those nations, giving those immigrants a deportation reprieve and access to work permits for an additional 18 months.
Biden, a Democrat, greatly increased the number of immigrants eligible for TPS since taking office in 2021. The status, which is available to people whose home country has experienced a natural disaster, armed conflict or other extraordinary event, now covers more than 1 million people from 17 nations.
Trump, a Republican returning to the White House on Jan. 20, sought to end most TPS enrollment during his 2017-2021 term in office but was stymied by U.S. courts. Trump won another term in office promising a vast immigration crackdown and again <a href="reuters://REALTIME/verb=NewsStory/ric=nL1N3CE1GR">is expected</a> to try to terminate most TPS protections.
Trump's transition team did not immediately respond to a request for comment.
The Biden administration's moves on Friday stopped short of more sweeping demands by activists and some Democrats to grant TPS to more recently arrived immigrants and those from other nations.
Todd Schulte, president of advocacy group FWD.us, said the extensions would allow hundreds of thousands of people to continue "contributing to their communities, supporting their families, and strengthening the economy" but also urged Biden to expand TPS to Nicaragua and other nations.
Some 600,000 Venezuelans are eligible for TPS, the biggest population in the program.
The Biden administration, which <a href="reuters://REALTIME/verb=NewsStory/ric=nL1N2L62GE">first granted</a> Venezuelans the status in 2021, cited high levels of crime in Venezuela related to political and economic instability under President Nicolas Maduro, who was <a href="reuters://REALTIME/verb=NewsStory/ric=nL1N3O50TP">sworn in</a> for a third term on Friday.

Macro Economic Events

Politics

Economics

General

"Biden Administration Renews Deportation Relief For 900,000 Immigrants From Venezuela, El Salvador, Ukraine And Sudan" - Reuters News

Hewlett Packard Enterprise shares are trading higher following a Bloomberg indicating that the company secured a $1 billion AI server deal for Elon Musk's X platform.

TLSA

Tiziana Life Sciences shares are trading higher after the company announced findings on the benefits of its nasal anti-CD3 monoclonal antibody.

<a href="https://www.bloomberg.com/news/articles/2025-01-10/hpe-wins-1-billion-ai-server-deal-for-elon-musk-s-x">https://www.bloomberg.com/news/articles/2025-01-10/hpe-wins-1-billion-ai-server-deal-for-elon-musk-s-x</a>
&nbsp;
Hewlett Packard Enterprise Co. won a deal worth more than $1 billion to provide Elon Musk's X social network with servers optimized for artificial intelligence work

Contracts

'HPE Wins $1 Billion AI Server Deal for Elon Musk's X' - Bloomberg News

Blackstone Explores Options For Liftoff That Could Value Company At More Than $4B

Hershey shares are trading lower following a report suggesting CEO Michelle Buck will depart.

Don and Tana lived paycheck to paycheck for years, barely keeping their heads above water. At 50 and 48, they resigned themselves to a future of endless work and no retirement. "We just assumed we'd work until we were dead," Tana admitted.
But then everything changed: their income skyrocketed from under $70,000 to $258,000 a year. That's when they <a href="https://www.benzinga.com/real-estate/24/10/41518597/renting-is-not-throwing-away-money-ramit-sethi-reveals-how-to-build-wealth-while-renting">turned to Ramit Sethi</a>, author of I Will Teach You to Be Rich and host of the podcast episode titled "We're $350K in Debt &amp; Have No Savings. Will I Have to Work Until We Die?"
Despite their newfound income, the couple's financial reality was still grim. They were drowning in $387,000 of debt and had no retirement savings. Earning more in a month than they used to make in a year hadn't solved the years of scarcity that left them stuck in survival mode. "We're not used to this. This isn't our world. We don't know what to do," Tana confessed on the podcast.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
On the show, Sethi broke down their situation and offered advice: get honest about the numbers, prioritize debt repayment and shift their mindset from scarcity to growth. His guidance wasn't just about fixing their finances but helping Don and Tana imagine a life beyond constant hustle.
The Debt and the Plan
Ramit broke down their situation: They had $387,000 in debt, including $51,000 in credit cards, $168,000 in student loans and a $12,000 car lease. They also had $200,000 in assets (mostly tied to their home) but only $11,000 in investments – far from what they'd need to secure their retirement.
"The part that is problematic is how little they have for investments and how much debt they have," Ramit noted. But their new monthly income of $21,500 gave them a rare opportunity to turn things around. "If they can keep their expenses low, they can certainly shovel money toward that debt."
See Also: Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a>
Shifting a Scarcity Mindset
Still, the numbers were only part of the problem. Years of financial struggle left Don and Tana with a mindset that Ramit described as common and deeply ingrained. "It's not really a joke," he said about the couple's tendency to <a href="https://www.benzinga.com/personal-finance/24/05/38845785/living-on-edge-nearly-90-of-retirees-worried-inflation-will-eat-away-savings">laugh off the idea of ever retiring</a>.&nbsp;
"They do it with a bit of a laugh, but also they believe it and they say it enough times and it starts to become a self-fulfilling prophecy."
Don recognized how his past shaped his perspective. "It was really hard for me to accept being paid what I'm worth," he admitted, describing the psychological hurdles of suddenly earning significantly more.
For Tana, the new stress came from the <a href="https://www.benzinga.com/personal-finance/24/06/39517838/couple-in-their-30s-make-850-000-a-year-yet-still-feel-behind-ramit-sethi-says-theyll-likely-spe">fear of mismanaging their finances</a>. "The stress now is more so about not screwing it up," she said. "We've had a lot of stuff happen to us throughout the years and so we're always waiting for the other shoe to drop."
Trending: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
Guilt-Free Spending
One of Ramit's strategies included carving out room for guilt-free spending, even as they tackled their debt. "One of the first things we bought was we replaced our measuring cups," Tana shared. Something as simple as replacing an old whisk now felt like a luxury.
The Path Forward
Don and Tana's journey proves that earning more doesn't automatically erase financial stress. It takes a strategic plan and the courage to confront long-held beliefs about money.
If you're dealing with a similar situation, whether it's debt, a new income or the struggle to shift your mindset, <a href="https://www.benzinga.com/money/are-you-rich">consulting with a financial advisor</a> can help. They'll work with you to create a plan tailored to your circumstances – so you can move from simply surviving to thriving.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

Personal Finance

We're $350,000 In Debt And Have No Savings At 50 – This Couple Making $258,000 A Year, Asks Ramit Sethi 'Will I Have To Work Until We Die?'

<a href="https://www.semafor.com/article/01/10/2025/hersheys-under-pressure-expected-to-replace-ceo" title="https://www.semafor.com/article/01/10/2025/hersheys-under-pressure-expected-to-replace-ceo">https://www.semafor.com/article/01/10/2025/hersheys-under-pressure-expected-to-replace-ceo</a>

Management

'Hershey, Under Pressure, To Lay Out CEO Departure' - Semafor

Snap-on's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) short percent of float has fallen 5.3% since its last report. The company recently reported that it has 2.09 million shares sold short, which is 4.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.18 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Snap-on Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736541022_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Snap-on has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Snap-on's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Snap-on's peer group average for short interest as a percentage of float is 4.45%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Snap-on's Recent Short Interest

BHP Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>) short percent of float has fallen 16.67% since its last report. The company recently reported that it has 8.97 million shares sold short, which is 0.35% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.38 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>BHP Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736541016_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for BHP Group has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing BHP Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, BHP Group's peer group average for short interest as a percentage of float is 5.86%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into BHP Group's Recent Short Interest

Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy

Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today and set a price target of $1...

Piper Sandler Keeps Their Buy Rating on Crispr Therapeutics AG (CRSP)

Bullish option flow detected in Crispr Therapeutics (CRSP) with 5,198 calls trading, 1.3x expected, and implied vol increasing over 3 points to 55....

Crispr Therapeutics call volume above normal and directionally bullish

SA Asks: Which Big Pharmas are likely to announce big M&A deals?

20:22 EST Cathie Wood's ARK Investment bought 58K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ultimate source for re...

Cathie Wood's ARK Investment bought 58K shares of Crispr Therapeutics today

Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025

Bullish option flow detected in Crispr Therapeutics (CRSP) with 3,137 calls trading, 1.3x expected, and implied vol increasing almost 2 points to 5...

CRISPR Therapeutics (CRSP) proposes to elect Briggs Morrison, M.D., to its Board of Directors at the Company's annual general meeting to be held th...

Crispr Therapeutics proposes to elect Briggs Morrison to board

2024 Performance Review And Future Strategy

Gene editing stocks drop as Intellia announces layoffs

ABBV

AMGN

ARQT

BIIB

CRSP

EDIT

GILD

KRYS

KURA

LENZ

MRNA

PRME

REGN

SDGR

SGMO

SMMT

TEVA

TSLA

VERV

VKTX

VRTX

VTRS

Press Releases

CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference

CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Earnings

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

Health Care

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Comments

CRISPR Therapeutics

Noticias

Últimas noticias sobre CRISPR Therapeutics (NASDAQ:CRSP) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL